FACE
| John A. van Aalst, MD | Cincinnati, OH |
The mission of the Journal FACE is to publish peer-reviewed manuscripts of the highest quality in order to communicate transformative knowledge and discoveries pertinent to all aspects of the art and science of the field of Craniomaxillofacial Surgery. The intention of FACE is to better inform clinicians, scientists and specialists in order to enlighten our readers and promote cutting-edge ideas and procedures that will benefit the patients for whom we care.
| John A. van Aalst, MD | Private Practice, Walton, KY, USA |
| Joseph E. Losee, MD, FACS, FAAP | University of Pittsburgh, Pittsburgh, PA, USA |
| Patrick Kelley, MD | Dell Children's Medical Center, Austin, TX, USA |
| Laura S. Humphries, MD | University of Mississippi Medical Center, Jackson, MS, USA |
| Francis A. Papay, MD | Cleveland Clinic Foundation, Cleveland, OH, USA |
| Gaby Doumit, MD | Cleveland Clinic and University of Montreal, Montreal, QC, Canada |
| Timothy W. King MD, PhD | University of Alabama Birmingham, Birmingham, AL, USA |
| Russell R. Reid, MD, PhD | University of Chicago, Chicago, IL, USA |
| Jack C. Yu, MD | Augusta University, Augusta, GA, USA |
| Devra B. Becker, MD | University of Pittsburgh Medical Center, Pittsburgh, PA, USA |
| Alexander Y. Lin, MD, MBA | University of California San Francisco, San Francisco, CA, USA |
| Kant Y. Lin, MD | University of Kentucky, Lexington, KY, USA |
| James P. Bradley, MD | Northwell Health, New York, NY, USA |
| Anand R. Kumar | Pediatrix Plastic and Reconstructive Surgery of Savannah, Savannah, GA, USA |
| Joseph K. Williams, MD | Atlanta Plastic Surgery, Atlanta, GA, USA |
| Stacey Francis, MD | Kaiser Permanente, Los Angeles, CA, USA |
| Raymond Harshbarger, MD, FACS | Dell Medical School, University of Texas, Austin, TX, USA |
| Seun Adetayo, MD, FAAP, FACS | University of Nebraska Medical Center, Omaha, NE, USA |
| Christian J. Vercler, MD | University of Michigan, Ann Arbor, MI, USA |
| William Y. Hoffman, MD | University of California San Francisco, San Francisco, CA, USA |
| James C. Lee, MD | Southern California Permanente Medical Group, Kaiser Permanente School of Medicine and Keck School of Medicine at USC, Los Angeles, CA, USA |
| John Henry N. Pang, MD | University of Pittsburgh Medical Center, Pittsburgh, PA, USA |
| Arun K. Gosain, MD | Northwestern University, Chicago, IL, USA |
| Delora L. Mount, MD | Louisiana State University Health Sciences Center, New Orleans, LA, USA |
| Brian Gastman, MD | Cleveland Clinic, Beachwood, OH, USA |
| Brian T. Andrews, MD | University of Kansas Medical Center, Kansas City, KS, USA |
| Thomas A. Imahiyerobo, MD | Columbia University Irving Medical Center and Morgan Stanley Children’s Hospital, New York, NY, USA |
| Janice Lalikos, MD | UMass Chan Medical School, Worcester, MA, USA |
| Paola Carvajal Monroy, PhD | Erasmus Medical Center and Sophia's Children's Hospital, Rotterdam, Amsterdam, The Netherlands |
| Michelle Scott, MD | Children’s Hospital of Philadelphia and University of Pennsylvania School of Dental Medicine, Philadelphia, PA, USA |
| Gregory Pearson, MD, FAAP, FACS | Nationwide Children's Hospital, Columbus, OH, USA |
| Peter J. Taub, MD | Mount Sinai Medical Center, New York, NY, USA |
| David J. Zajac, PhD | UNC Adams School of Dentistry and UNC Medical Center, Chapel Hill, NC, USA |
| Michael R. Christy, MD | Long Island Plastic Surgical Group, Garden City, NY, USA |
| Peter Anderson, MD | Cleft & Craniofacial Unit of South Australia, Adelaide, Australia |
| Cassio Raposo do Amaral, MD, PhD | Hospital Sobrapar, Campinas, Brazil |
| Amir Elbabary, MD | Ain Shams University, Cairo, Egypt |
| Khaldoun Jalal Haddadin, MD | King Hussein Cancer Center, Amman, Jordan |
| Lun-Jou Lo, MD | Chiayi Chang Gung Memorial Hospital, Taoyuan, Taiwan |
| Irene Mathijssen, MD, PhD | Erasmus University Rotterdam, Rotterdam, The Netherlands |
| Ikram Seif, MD | Ain-Shams University, Cairo, Egypt |
| Divya Narain Upadhyaya, MCh, FACS | King George’s Medical University, Lucknow, India |
| Tien-Hsiang Wang, MD | Taipei Veterans General Hospital, Taipei, Taiwan |
| Issam Zahiri, MD | University of Tunis, El Manar, Tunis, Tunisia |
| Karin M. Muraszko, MD | University of Michigan, Ann Arbor, MI, USA |
| Steven R. Buchman, MD | University of Michigan and C. S. Mott Children's Hospital, Ann Arbor, MI, USA |
- Scopus
This Journal is a member of the Committee on Publication Ethics.
This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Please read the guidelines below then visit the FACE submission site to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned. Remember you can log in to the submission site at any time to check on the progress of your paper through the peer review process.
SAGE Publishing is committed to disseminating high-quality research and engaged scholarship globally. As part of this commitment, we value Diversity and Inclusion in publishing. We therefore encourage submissions from a diverse range of authors from across all countries and backgrounds.
Only manuscripts of sufficient quality that meet the aims and scope of FACE will be reviewed.
There are no fees payable to submit or publish in this Journal.
As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere. Please see our guidelines on prior publication and note that FACE will consider submissions of papers that have been posted on preprint servers; please alert the Editorial Office when submitting (contact details are at the end of these guidelines) and include the DOI for the preprint in the designated field in the manuscript submission system. Authors should not post an updated version of their paper on the preprint server while it is being peer reviewed for possible publication in the Journal. If the article is accepted for publication, the author may re-use their work according to the Journal's author archiving policy. If your paper is accepted, you must include a link on your preprint to the final version of your paper.
If you have any questions about publishing with SAGE, please visit the SAGE Journal Solutions Portal.
1. What do we publish?
1.1 Aims & Scope
1.2 Article types
1.3 Writing your paper
2. Editorial policies
2.1 Peer review policy
2.2 Authorship
2.3 Acknowledgements
2.4 Funding
2.5 Declaration of conflicting interests
2.6 Research ethics and patient consent
2.7 Clinical trials
2.8 Reporting guidelines
2.9 Research data
3. Publishing policies
3.1 Publication ethics
3.2 Contributor’s publishing agreement
3.3 Open access and author archiving
4. Preparing your manuscript
4.1 Formatting
4.2 Artwork, figures and other graphics
4.3 Supplemental material
4.4 Reference style
4.5 English language editing services
5. Submitting your manuscript
5.1 ORCID
5.2 Information required for completing your submission
5.3 Permissions
6. On acceptance and publication
6.1 SAGE Production
6.2 Online First publication
6.3 Access to your published article
6.4 Promoting your article
7. Further information
7.1 Appealing the publication decision
1. What do we publish?
1.1 Aims & Scope
The mission of the Journal FACE is to publish peer-reviewed manuscripts of the highest quality in order to communicate transformative knowledge and discoveries pertinent to all aspects of the art and science of the field of Craniomaxillofacial Surgery. The intention of FACE is to better inform clinicians, scientists and specialists in order to enlighten our readers and promote cutting-edge ideas and procedures that will benefit the patients for whom we care.
1.2 Article types
FACE will consider any original article, including case reports and case series, retrospective and prospective clinical studies, animal studies, and basic science research. The Journal will also consider review articles, letters to the editor, book reviews, surgical techniques, and historical papers.
- Original Articles: maximum of 7,000 words, with up to 6 figures or tables combined
- Review Articles: maximum of 4,500 words, with up to 6 figures or tables combined
- Case Reports: maximum of 4,000 words, with up to 6 figures or tables combined
- Letter to the Editor: maximum of 1,500 words, with up to 1 figure or table
- "In Your FACE": consists of Narrative Content, Essays or Editorials from members of ASMS and ASCFS. Suggested topics include Personal/Professional Challenges, Mentorship, Diversity and Inclusion, Leadership, Well-Being and Political Advocacy.
The Journal allows as many citations and references as the authors feel necessary for the manuscript.
1.3 Writing your paper
The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources. SAGE Author Services also offers authors a variety of ways to improve and enhance their article including English language editing, plagiarism detection, and video abstract and infographic preparation.
.
1.3.1 Make your article discoverable
For information and guidance on how to make your article more discoverable, visit our Gateway page on How to Help Readers Find Your Article Online.
2. Editorial policies
2.1 Peer review policy
FACE operates a conventional single-anonymized reviewing policy in which the reviewer’s name is always concealed from the submitting author. Each manuscript is reviewed by at least two reviewers. Reviewers make comments to the author and recommendations to the Editor who then makes the final decision.
As standard practice, SAGE does not permit the use of author-suggested reviewers. Reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Our policy is that reviewers should not be assigned to a paper if:
- The reviewer is based at the same institution as any of the co-authors
- The reviewer is based at the funding body of the paper
- The author has recommended the reviewer
- The reviewer has provided a personal (e.g. Gmail/Yahoo/Hotmail) email account and an institutional email account cannot be found after performing a basic Google search (name, department and institution).
2.2 Authorship
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
- Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
- Drafted the article or revised it critically for important intellectual content,
- Approved the version to be published,
- Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Authors should meet the conditions of all of the points above. When a large, multicenter group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.
2.3 Acknowledgements
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.
Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.
2.3.1 Writing assistance
Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance. It is not necessary to disclose use of language polishing services.
2.4 Funding
FACE requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
2.5 Declaration of conflicting interests
It is the policy of FACE to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’. For guidance on conflict of interest statements, please see the ICMJE recommendations here.
2.6 Research ethics and patient consent
Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki.
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant ethics committee or institutional review board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.
For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.
Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative. Please do not submit the patient’s actual written informed consent with your article, as this in itself breaches the patient’s confidentiality. The Journal requests that you confirm to us, in writing, that you have obtained written informed consent but the written consent itself should be held by the authors/investigators themselves, for example in a patient’s hospital record. The confirmatory letter may be uploaded with your submission as a separate file.
Please also refer to the ICMJE Recommendations for the Protection of Research Participants.
All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The Journal has adopted the ARRIVE guidelines.
2.7 Clinical trials
FACE conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
2.8 Reporting guidelines
The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.
Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.
2.9 Research data
The journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the SAGE Research Data policy pages.
Subject to appropriate ethical and legal considerations, authors are encouraged to:
- share your research data in a relevant public data repository
- include a data availability statement linking to your data. If it is not possible to share your data, we encourage you to consider using the statement to explain why it cannot be shared.
- cite this data in your research
3. Publishing policies
3.1 Publication ethics
SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway.
3.1.1 Plagiarism
FACE and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the Journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.
3.1.2 Prior publication
If material has been previously published it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.
3.2 Contributor’s publishing agreement
Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive license agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and license to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit the SAGE Author Gateway.
3.3 Open access and author archiving
FACE offers optional open access publishing via the SAGE Choice program. For more information please visit the SAGE Choice website. For information on funding body compliance, and depositing your article in repositories, please visit SAGE Publishing Policies on our Journal Author Gateway.
4. Preparing your manuscript for submission
4.1 Formatting
The preferred format for your manuscript is Word. LaTeX files are also accepted. A LaTex template is available on the Manuscript Submission Guidelines page of our Author Gateway.
4.2 Artwork, figures and other graphics
For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines.
Figures supplied in color will appear in color online regardless of whether or not these illustrations are reproduced in color in the printed version. For specifically requested color reproduction in print, you will receive information regarding the costs from SAGE after receipt of your accepted article.
4.3 Supplemental material
This Journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc.) alongside the full-text of the article. For more information please refer to our guidelines on submitting supplemental files.
4.4 Reference style
FACE adheres to the AMA Manual of Style. View the guide here to ensure your manuscript conforms to this style.
4.5 English language editing services
Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the Journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.
5. Submitting your manuscript
FACE is hosted on SAGE Track, a web based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit https://mc.manuscriptcentral.com/face to login and submit your article online.
IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the Journal in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit ScholarOne Online Help.
5.1 ORCID
As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.
The collection of ORCID IDs from corresponding authors is now part of the submission process of this Journal. If you already have an ORCID ID you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID ID will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID ID is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.
If you do not already have an ORCID ID please follow this link to create one or visit our ORCID homepage to learn more.
5.2 Information required for completing your submission
You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. The affiliation listed in the manuscript should be the institution where the research was conducted. If an author has moved to a new institution since completing the research, the new affiliation can be included in a manuscript note at the end of the paper. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).
5.3 Permissions
Please also ensure that you have obtained any necessary permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please see the Copyright and Permissions page on the SAGE Author Gateway.
6. On acceptance and publication
6.1 SAGE Production
Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be made available to the corresponding author via our editing portal SAGE Edit or by email, and corrections should be made directly or notified to us promptly. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate.
6.2 Online First publication
Online First allows final articles (completed and approved articles awaiting assignment to a future issue) to be published online prior to their inclusion in a journal issue, which significantly reduces the lead time between submission and publication. Visit the SAGE Journals help page for more details, including how to cite Online First articles.
6.3 Access to your published article
SAGE provides authors with online access to their final article.
6.4 Promoting your article
Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice.
Follow and tag @FACEJournal_ and @SAGEClinMed on Twitter to promote your paper and stay up-to-date on the latest news from the Journal.
7. Further information
Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the FACE editorial office as follows:
John van Aalst, MD
johnavanaalst@gmail.com
7.1 Appealing the publication decision
Editors have very broad discretion in determining whether an article is an appropriate fit for their journal. Many manuscripts are declined with a very general statement of the rejection decision. These decisions are not eligible for formal appeal unless the author believes the decision to reject the manuscript was based on an error in the review of the article, in which case the author may appeal the decision by providing the Editor with a detailed written description of the error they believe occurred.
If an author believes the decision regarding their manuscript was affected by a publication ethics breach, the author may contact the publisher with a detailed written description of their concern, and information supporting the concern, at publication_ethics@sagepub.com